Sheila Chitsaz Lahijani, MD
Psychiatry · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lahijani’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A137837 · Current
Licensed to practise in California · since 2015 · expires 2026-11-30 · The Warren Alpert School of Medicine of Brown University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Illinois 036129114Licensed Physician And Surgeon · since 2011 · expires 2020-09-30Not RenewedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$42,523
Medicare paid this office $42,523 for 119 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 38 | $12,089 | $121 |
| Psychiatric diagnostic evaluation with medical services | 64 | $10,011 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $7,405 | $71 |
| Psychiatric diagnostic evaluation with medical services | 21 | $3,573 | $170 |
| Short return visit (20+ min) | 19 | $2,503 | $83 |
See all 6 services
| Return visit (30+ min) | 38 | $12,089 | $121 |
| Psychiatric diagnostic evaluation with medical services | 64 | $10,011 | $149 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $7,405 | $71 |
| Psychiatric diagnostic evaluation with medical services | 21 | $3,573 | $170 |
| Short return visit (20+ min) | 19 | $2,503 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $1,475 | $64 |
Who their Medicare patients are
119 Original Medicare patients in 2024. Average age 72 · Women 64% · Also on Medicaid 29% · Health risk score 3.10. Sicker patients than 9 in 10 peers; the typical psychiatry clinician is at 1.35.
Conditions among them: High blood pressure 72% · Depression 61% · Cancer 41% · Dementia 34% · Coronary heart disease 33% · Diabetes 29% · Chronic kidney disease 29% · Heart failure 22% · Stroke 20% · COPD 18% · Atrial fibrillation 18%.
The office billed $238,584, Medicare allowed $54,187 and paid $42,523; for 395 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 119 | 395 | 72 | 3.10 | $238,584 | $42,523 |
| 2023 | 95 | 430 | 68 | 2.69 | $231,639 | $36,372 |
| 2022 | 84 | 408 | 70 | 2.26 | $222,458 | $36,005 |
| 2021 | 81 | 381 | 67 | 3.07 | $224,725 | $32,806 |
| 2020 | 125 | 585 | 68 | 2.72 | $260,080 | $46,919 |
| 2019 | 141 | 488 | 66 | 2.96 | $166,004 | $45,103 |
| 2018 | 168 | 634 | 66 | 2.75 | $178,645 | $59,197 |
| 2017 | 193 | 543 | 64 | 2.59 | $154,422 | $49,808 |
| 2016 | 263 | 911 | 65 | 2.84 | $276,560 | $81,986 |
| 2015 | 103 | 254 | 64 | 2.53 | $70,369 | $19,114 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Psychiatric diagnostic evaluation with medical services | 68 | $10,935 | $150 |
| Return visit (30+ min) | 24 | $6,797 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $4,159 | $73 |
| Psychotherapy with evaluation and management visit, 30 minutes | 22 | $3,460 | $55 |
| Short return visit (20+ min) | 21 | $2,135 | $59 |
2022: 7 services
| Psychiatric diagnostic evaluation with medical services | 63 | $10,128 | $156 |
| Return visit (30+ min) | 24 | $7,334 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $4,188 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,777 | $65 |
| Psychotherapy with evaluation and management visit, 30 minutes | 20 | $2,647 | $56 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $1,419 | $68 |
| Short return visit (20+ min) | 14 | $1,284 | $61 |
2021: 3 services
| Return visit (30+ min) | 37 | $13,209 | $90 |
| Psychiatric diagnostic evaluation with medical services | 38 | $5,880 | $155 |
| Psychotherapy with evaluation and management visit, 30 minutes | 24 | $3,680 | $57 |
2020: 9 services
| Psychiatric diagnostic evaluation with medical services | 68 | $9,939 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $7,181 | $97 |
| Return visit (30+ min) | 25 | $4,962 | $72 |
| Psychotherapy with evaluation and management visit, 30 minutes | 32 | $3,939 | $55 |
| New patient visit (60+ min) | 23 | $3,701 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,122 | $68 |
| Psychotherapy with evaluation and management visit, 45 minutes | 22 | $3,011 | $68 |
| Short return visit (20+ min) | 22 | $2,436 | $47 |
| Short return visit (20+ min) | 11 | $772 | $51 |
2019: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $12,387 | $92 |
| Psychiatric diagnostic evaluation with medical services | 73 | $8,701 | $118 |
| Long return visit (40+ min) | 34 | $5,794 | $97 |
| Psychotherapy with evaluation and management visit, 1 hour | 23 | $3,496 | $92 |
| New patient visit (60+ min) | 21 | $3,198 | $152 |
| Psychotherapy with evaluation and management visit, 45 minutes | 23 | $2,792 | $72 |
| Psychotherapy with evaluation and management visit, 30 minutes | 20 | $1,781 | $54 |
| Return visit (30+ min) | 15 | $1,579 | $72 |
| Short return visit (20+ min) | 11 | $975 | $46 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $14,605 | $94 |
| Psychotherapy with evaluation and management visit, 1 hour | 49 | $8,169 | $93 |
| Psychiatric diagnostic evaluation with medical services | 59 | $7,955 | $124 |
| Return visit (30+ min) | 37 | $6,522 | $70 |
| Long return visit (40+ min) | 30 | $5,786 | $100 |
| New patient visit (60+ min) | 38 | $5,719 | $151 |
| Psychotherapy with evaluation and management visit, 45 minutes | 22 | $3,399 | $72 |
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $1,834 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,344 | $122 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $21,486 | $93 |
| Psychotherapy with evaluation and management visit, 1 hour | 30 | $6,972 | $96 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 60 | $5,562 | $90 |
| Return visit (30+ min) | 29 | $5,291 | $71 |
| New patient visit (60+ min) | 27 | $4,059 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,831 | $122 |
| Long return visit (40+ min) | 11 | $1,196 | $100 |
2016: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 135 | $41,725 | $92 |
| Psychotherapy with evaluation and management visit, 1 hour | 33 | $10,112 | $95 |
| Return visit (30+ min) | 44 | $9,252 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,860 | $121 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 51 | $4,550 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $3,142 | $64 |
| New patient visit (60+ min) | 15 | $2,246 | $150 |
| Long return visit (40+ min) | 18 | $1,982 | $99 |
| New patient visit (45+ min) | 14 | $1,615 | $115 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 53 | $7,984 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,386 | $93 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 26 | $2,517 | $90 |
| Return visit (30+ min) | 16 | $1,476 | $70 |
Medicaid work
$983 in 2022
Medicaid paid $983 for 18 billed services this clinician did in 2022, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Psychiatric diagnostic evaluation with medical services | 18 | $983 |
| 2022 | 18 | 1 | 16 | $983 |
Drugs they prescribed that Part D paid
$3,592
Pharmacies billed $3,592 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 200) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
198 generic and fewer than 11 brand-name prescriptions · $3,592 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Duloxetine | 26 | $913 | $35 |
| Mirtazapine | 29 | $417 | $14 |
| Hydroxyzine | 16 | $386 | $24 |
| Gabapentin | 11 | $239 | $22 |
| Escitalopram | 23 | $224 | $10 |
See all 9 drugs
| Duloxetine | 26 | $913 | $35 |
| Mirtazapine | 29 | $417 | $14 |
| Hydroxyzine | 16 | $386 | $24 |
| Gabapentin | 11 | $239 | $22 |
| Escitalopram | 23 | $224 | $10 |
| Bupropion Xl | 15 | $184 | $12 |
| Bupropion | 13 | $108 | $8 |
| Sertraline | 22 | $100 | $5 |
| Lorazepam | 12 | $70 | $6 |
Year by year
| 2024 | 200 | 39 | 0% (0) | None | $3,592 |
| 2023 | 167 | 30 | 0% (0) | 0% | $3,493 |
| 2022 | 130 | 26 | 0% (0) | 0% | $2,573 |
| 2021 | 209 | 42 | 0% (0) | 0% | $3,831 |
| 2020 | 196 | 39 | 0% (0) | 0% | $3,230 |
| 2019 | 186 | 44 | 0% (0) | 0% | $3,740 |
| 2018 | 244 | 42 | 0% (0) | 0% | $4,793 |
| 2017 | 170 | 41 | 0% (0) | None | $10,636 |
| 2016 | 141 | 31 | 0% (0) | None | $21,335 |
| 2015 | 49 | 15 | 0% (0) | None | $677 |
| 2014 | 12 | None | 0% (0) | 0% | $242 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Duloxetine | 28 | $1,045 | $37 |
| Hydroxyzine | 23 | $453 | $20 |
| Mirtazapine | 18 | $155 | $9 |
| Escitalopram | 15 | $154 | $10 |
| Gabapentin | 12 | $122 | $10 |
| Lorazepam | 13 | $99 | $8 |
2022: 2 drugs
| Duloxetine | 17 | $444 | $26 |
| Hydroxyzine | 19 | $192 | $10 |
2021: 7 drugs
| Mirtazapine | 17 | $359 | $21 |
| Gabapentin | 24 | $331 | $14 |
| Hydroxyzine | 21 | $322 | $15 |
| Escitalopram | 26 | $320 | $12 |
| Sertraline | 19 | $241 | $13 |
| Lorazepam | 23 | $170 | $7 |
| Fluoxetine | 11 | $147 | $13 |
2020: 5 drugs
| Hydroxyzine | 43 | $603 | $14 |
| Sertraline | 20 | $321 | $16 |
| Escitalopram | 17 | $200 | $12 |
| Gabapentin | 17 | $187 | $11 |
| Lorazepam | 22 | $127 | $6 |
2019: 8 drugs
| Duloxetine | 14 | $693 | $49 |
| Escitalopram | 25 | $522 | $21 |
| Mirtazapine | 13 | $298 | $23 |
| Hydroxyzine | 20 | $268 | $13 |
| Bupropion Xl | 11 | $254 | $23 |
| Gabapentin | 16 | $217 | $14 |
| Sertraline | 29 | $200 | $7 |
| Olanzapine | 13 | $135 | $10 |
2018: 8 drugs
| Gabapentin | 40 | $1,121 | $28 |
| Hydroxyzine | 19 | $404 | $21 |
| Sertraline | 38 | $288 | $8 |
| Duloxetine | 14 | $288 | $21 |
| Lorazepam | 23 | $283 | $12 |
| Olanzapine | 33 | $194 | $6 |
| Bupropion Xl | 12 | $186 | $16 |
| Citalopram Hbr | 15 | $76 | $5 |
2017: 7 drugs
| Gabapentin | 16 | $1,080 | $67 |
| Mirtazapine | 17 | $574 | $34 |
| Bupropion Xl | 12 | $427 | $36 |
| Lorazepam | 21 | $204 | $10 |
| Sertraline | 13 | $104 | $8 |
| Escitalopram | 13 | $56 | $4 |
| Olanzapine | 11 | $52 | $5 |
2016: 4 drugs
| Bupropion Hcl Sr | 18 | $646 | $36 |
| Sertraline | 26 | $149 | $6 |
| Gabapentin | 15 | $95 | $6 |
| Lorazepam | 11 | $86 | $8 |
2015: 1 drug
| Mirtazapine | 11 | $105 | $10 |
Money from drug and device companies
$274 in 2024
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | None | $274 | 3 payments
|
See all 3 published payments
| AstraZeneca Pharmaceuticals LP | Travel · 2024-06-14 | None | $38 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2024-04-26 | None | $149 |
| AstraZeneca Pharmaceuticals LP | Travel · 2024-02-28 | None | $87 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1528224235
- Licence
- CA A137837, IL 036129114California A137837: Current · expires 2026-11-30Illinois 036129114: Not Renewed
- Trained
- Warren Alpert Medical School of Brown University, 2007
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2084P0015X (2084P0015X); Internal medicine (207R00000X); Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-08-01
- NPI last updated
- 2024-09-24
- NPI record certified
- 2024-09-24
This is when the NPI record was last certified, not a medical board exam.